Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures
Crossref DOI link: https://doi.org/10.1007/s00415-017-8618-5
Published Online: 2017-09-18
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Villanueva, Vicente
Holtkamp, Martin
Delanty, Norman
Rodriguez-Uranga, Juan
McMurray, Rob
Santagueda, Patricia
Funding for this research was provided by:
Eisai Ltd
License valid from 2017-09-18